Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study

Autor: Bernard Rubin, Yan Chen, Karen Worley, Brendan Rabideau, Benson Wu, Rose Chang, Maral DerSarkissian

Publikováno v: Rheumatology and Therapy, Vol 11, Iss 4, Pp 947-962 (2024)

Abstract Introduction Patients with systemic lupus erythematosus (SLE) have variable treatment pathways, including antimalarials, glucocorticoids, immunosuppressants, and/or biologics. This study describes differences in clinical outcomes when initia

Externí odkaz: https://doaj.org/article/f629fc5813a2485380e58d4e10596334

The Effects of Telemedicine on the Treatment of Mental Illness: Evidence from Changes in Health Plan Benefits

Autor: Brendan Rabideau, Matthew D. Eisenberg

Publikováno v: SSRN Electronic Journal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbcbb33ee8d04a6d2944ac2022651503
https://doi.org/10.2139/ssrn.4065120

Impact of consumer-directed health plans on low-value healthcare

Autor: Rachel O, Reid, Brendan, Rabideau, Neeraj, Sood

Publikováno v: The American journal of managed care. 23(12)

To assess the impact of consumer-directed health plan (CDHP) enrollment on low-value healthcare spending.We performed a quasi-experimental analysis using insurance claims data from 376,091 patients aged 18 to 63 years continuously enrolled in a plan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acf2df492df10d9fcd0a66cfd3701c88
https://pubmed.ncbi.nlm.nih.gov/29261240

HF Mortality Trends Under Medicare Readmissions Reduction Program at Penalized and Nonpenalized Hospitals

Autor: José J. Escarce, Brendan Rabideau, Neeraj Sood, Peter J. Huckfeldt, Andrew Wilcock, Teryl K. Nuckols, Ioana Popescu

Publikováno v: Journal of the American College of Cardiology. 72:2539-2540

After announcement and implementation of the Medicare Hospital Readmissions Reduction Program (HRRP), 30-day readmissions declined rapidly among seniors with heart failure (HF) while 30-day mortality rose [(1)][1]. This raised questions about whether

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e8e44c0d20a07c377c2c5e15e259789
https://doi.org/10.1016/j.jacc.2018.08.2174

Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service.

Autor: Huckfeldt PJ; Peter J. Huckfeldt (huckfeld@umn.edu) is an assistant professor in the Division of Health Policy and Management, School of Public Health, University of Minnesota, in Minneapolis., Escarce JJ; José J. Escarce is a professor of medicine in the David Geffen School of Medicine, University of California, Los Angeles., Rabideau B; Brendan Rabideau is a research programmer at the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, in Los Angeles., Karaca-Mandic P; Pinar Karaca-Mandic is an associate professor in the Division of Health Policy and Management, School of Public Health, University of Minnesota., Sood N; Neeraj Sood is a professor and vice dean for research at the Sol Price School for Public Policy and director of research at the Leonard D. Schaeffer Center for Health Policy and Economics, both at the University of Southern California.

Publikováno v: Health affairs (Project Hope) [Health Aff (Millwood)] 2017 Jan 01; Vol. 36 (1), pp. 91-100.